Firm wielding Theranos patents asks judge to block coronavirus test [Updated] | Ars Technica

Back in 2018, the disgraced biotech company Theranos sold its patent portfolio to Fortress Investment Group, a division of Softbank. Now two of those patents have wound up in the hands of a little-known firm called Labrador Diagnostics—and Labrador is suing a company called BioFire Diagnostics that makes medical testing equipment.And not just any medical testing equipment: BioFire recently announced it had developed three tests for COVID-19 using its hardware—tests that are due out later this month. But Labrador is asking a Delaware federal court to block the company from using its technology—presumably including the new coronavirus tests. As Stanford patent scholar Mark Lemley puts it, “this could be the most tone-deaf IP suit in history.”

Source: Firm wielding Theranos patents asks judge to block coronavirus test [Updated] | Ars Technica

Check out this surreal chat with Theranos investor who says he’s “thrilled” | Ars Technica


He lost $500,000, but you wouldn’t know it from listening to him.

Source: Check out this surreal chat with Theranos investor who says he’s “thrilled” | Ars Technica

Theranos’ downfall due to elaborate $4M conspiracy, investor says | Ars Technica


Last remaining defender goes to bat for company as more blunders come to light.

Source: Theranos’ downfall due to elaborate $4M conspiracy, investor says | Ars Technica